âšď¸ Skipped - page is already crawled
| Filter | Status | Condition | Details |
|---|---|---|---|
| HTTP status | PASS | download_http_code = 200 | HTTP 200 |
| Age cutoff | PASS | download_stamp > now() - 6 MONTH | 0.3 months ago |
| History drop | PASS | isNull(history_drop_reason) | No drop reason |
| Spam/ban | PASS | fh_dont_index != 1 AND ml_spam_score = 0 | ml_spam_score=0 |
| Canonical | PASS | meta_canonical IS NULL OR = '' OR = src_unparsed | Not set |
| Property | Value |
|---|---|
| URL | https://nyulangone.org/news/severely-stressful-events-worsen-symptoms-long-covid |
| Last Crawled | 2026-04-10 13:02:18 (8 days ago) |
| First Indexed | 2022-11-09 18:42:51 (3 years ago) |
| HTTP Status Code | 200 |
| Meta Title | Severely Stressful Events Worsen Symptoms of Long COVID | NYU Langone News |
| Meta Description | NYU Langone study reveals stressful life events as a predictor of whether patients go on to develop long COVID. Learn more. |
| Meta Canonical | null |
| Boilerpipe Text | T
he death of a loved one, financial or food insecurity, or a newly developed disability were some of the strongest predictors of whether a patient hospitalized for COVID-19 would experience symptoms of long COVID a year later, a new study finds.
Led by researchers from NYU Grossman School of Medicine, the study found that adult patients with such âmajor life stressorsââpresent in more than 50 percent of those followedâwere at least twice as likely to struggle with depression, brain fog, fatigue, sleep problems, and other long-term COVID-19 symptoms.
Published online this week in the
Journal of the Neurological Sciences
(link is external)
, the analysis also confirmed the contribution of traditional factors to greater long COVID risk as shown by past studiesâolder age, disability level to start with, and a more severe initial case of COVID-19.
âOur study is unique in that it explores the impact of life stressorsâalong with demographic trends and neurologic eventsâas predictors of long-term cognitive and functional disabilities that affected quality of life in a large population,â says lead study author
Jennifer A. Frontera, MD
, professor in the
Department of Neurology
(link is external)
at NYU Langone Health. âTherapies that lessen the trauma of the most stress-inducing life events need to be a central part of treatment for long COVID, with more research needed to validate the best approaches.â
The research used standard telephone survey tools in the fieldâthe modified Rankin Scale (mRS), the Barthel Index, the Montreal Cognitive Assessment (t-MoCA), and the National Institutes of Health (NIH)/Patient-Reported Outcomes Measurement Information System (PROMIS) Neurological Quality Of Life (NeuroQoL) batteriesâto measure level of daily function, clear thinking (cognition),
anxiety
,
depression
, fatigue, and sleep quality. The team attempted to follow up with each of 790 patients 6 months and a year after COVID-19 hospitalization within NYU Langone Health between March 10, 2020, and May 20, 2020.
Of these surviving patients, 451 (57 percent) completed a 6-month and/or 12-month follow-up, and, of them, 17 percent died between discharge and 12-month follow-up and 51 percent reported significant life stressors at 12 months.
In analyses that compared factors against each other for their contribution to worse outcomes, life stressors including financial insecurity, food insecurity, death of a close contact, and new disability were the strongest independent predictors of prolonged COVID-19 symptoms. These same stressors also best predicted worse functional status, depression, fatigue, sleep scores, and reduced ability to participate in activities of daily living such as feeding, dressing, and bathing.
Gender was also a contributor, as past studies have found that women are more susceptible in general to, for instance, autoimmune diseases that could have an impact on outcomes. Additionally, undiagnosed mood disorders may have been unmasked by pandemic-related stressors.
Neurologic Long COVID May Include More Than One Condition
A second study led by Dr. Frontera and colleagues, and
published online September 29, 2022, in
PLOS ONE
(link is external)
, found that patients diagnosed as having long COVID neurologic problems can be divided into three symptom groups.
Because there is no current biological definition long COVID, many studies lump disparate symptoms into what is currently a blanket diagnosis, and without an assessment of clinical relevance, says Dr. Frontera. The resulting vagueness has made it âdifficult to assess treatment strategies.â
For the
PLOS One
study, the research team collected data on symptoms, treatments received, and outcomes for 12 months after hospitalization with COVID-19, with treatment success measured again by standard metrics (modified Rankin Scale, Barthel Index, NIH NeuroQoL). The three newly identified disease groups were as follows:
Cluster 1: few symptoms (most commonly
headache
) who received few therapeutic interventions
Cluster 2: many symptoms including anxiety and depression who received several treatments, including
antidepressants
to
psychological therapy
Cluster 3: primarily pulmonary symptoms such as shortness of breath; many patients also complained of headache and cognitive symptoms, and mostly received physical therapy
The most severely affected patients (symptom Cluster 2) had higher rates of disability and worse measures of anxiety, depression, fatigue, and sleep disorders. All patients whose treatment included psychiatric therapies reported symptom improvement, compared to 97 percent who received primarily physical or occupational therapy, and 83 percent who received few interventions.
The Brookings Institution estimated in August 2022 that roughly 16 million working-age Americans (aged 18 to 65) have long COVID, out of which 2 to 4 million are out of work due to long COVID.
Along with Dr. Frontera, authors of the
Journal of the Neurological Sciences
study from the Department of Neurology at NYU Langone Health were
Sakinah B. Sabadia
,
Ariane Lewis
,
Aaron S. Lord
,
Kara R. Melmed
,
Sujata P. Thawani
,
Laura J. Balcer
,
Thomas M. Wisniewski
, and
Steven L. Galetta
. Also authors were Dixon Yang of the Department of Neurology at NewYork-Presbyterian, Columbia Medical Center; Adam de Havenon in the Department of Neurology at Yale University School of Medicine; and Shadi Yaghi in the Department of Neurology at Brown University School of Medicine.
Media Inquiries
Greg Williams
Phone: 212-404-3500
gregory.williams@nyulangone.org
(link sends email) |
| Markdown | - We use cookies and similar tools to give you the best website experience. By using our site, you accept our [Websites Privacy Policy](https://nyulangone.org/policies-disclaimers/websites-privacy-policy).
- Close
[If you need help accessing our website, call 855-698-9991](tel:855-698-9991)
- [Patient Care](https://nyulangone.org/)
- Education & Research
- [NYU Grossman School of Medicine](https://med.nyu.edu/)
- [NYU Grossman Long Island School of Medicine](https://medli.nyu.edu/)
- [MyChart Patient Login](https://mychart.nyulmc.org/mychart/)
- [Patient Forms](http://nyulangone.org/patient-forms)
- [Contact Us](http://nyulangone.org/contact-us)
- [Give](https://give.nyulangone.org/)
- [Education & Research](https://nyulangone.org/news/severely-stressful-events-worsen-symptoms-long-covid)
- [NYU Grossman School of Medicine](http://med.nyu.edu/)
- [NYU Grossman Long Island School of Medicine](http://medli.nyu.edu/)
[](https://nyulangone.org/)
[](https://nyulangone.org/news)
[Jump to site navigation](https://nyulangone.org/news/severely-stressful-events-worsen-symptoms-long-covid#navigation)
Filter News by Category
- [For Journalists](https://nyulangone.org/news/for-journalists)
- [Press Releases](https://nyulangone.org/news/press-releases)
- [Patient Care](https://nyulangone.org/news/patient-care)
- [Education](https://nyulangone.org/news/education)
- [Research](https://nyulangone.org/news/research)
- [Artificial Intelligence](https://nyulangone.org/news/artificial-intelligence)
- [Translational Medicine](https://nyulangone.org/news/translational-medicine)
- [Digital Health](https://nyulangone.org/news/digital-health)
- [Leaders in Medicine](https://nyulangone.org/news/leaders-medicine)
- [Innovation](https://nyulangone.org/news/innovation)
- [Complex Cases](https://nyulangone.org/news/complex-cases)
- [Locations](https://nyulangone.org/news/locations)
- [In the Media](https://nyulangone.org/news/media)
- [Honors & Awards](https://nyulangone.org/news/honors-awards)
Search this site
[Ask AI](https://nyulangone.org/ai-assistant)
[Research](https://nyulangone.org/news/research), [Press Releases](https://nyulangone.org/news/press-releases)
\|
November 9, 2022
Severely Stressful Events Worsen Symptoms of Long COVID

Photo: Twenty47studio/Getty
- [Twitter](https://twitter.com/intent/tweet?url=https%3A//nyulangone.org/news/severely-stressful-events-worsen-symptoms-long-covid&text=Severely%20Stressful%20Events%20Worsen%20Symptoms%20of%20Long%20COVID "Twitter, ")
- [Facebook](https://www.facebook.com/sharer/sharer.php?u=https%3A//nyulangone.org/news/severely-stressful-events-worsen-symptoms-long-covid"e=Severely%20Stressful%20Events%20Worsen%20Symptoms%20of%20Long%20COVID "Facebook, ")
## In this article
### Our Experts
- [Jennifer A. Frontera, MD](https://nyulangone.org/doctors/1669420550/jennifer-a-frontera)
- [Sakinah B. Sabadia, MD](https://nyulangone.org/doctors/1578919122/sakinah-b-sabadia)
- [Ariane Lewis, MD](https://nyulangone.org/doctors/1700046075/ariane-lewis)
- [Aaron S. Lord, MD](https://nyulangone.org/doctors/1477759058/aaron-s-lord)
- [Kara R. Melmed, MD](https://nyulangone.org/doctors/1013354745/kara-r-melmed)
- [Sujata P. Thawani, MD, MPH](https://nyulangone.org/doctors/1043549108/sujata-p-thawani)
- [Laura J. Balcer, MD](https://nyulangone.org/doctors/1902838121/laura-j-balcer)
- [Thomas M. Wisniewski, MD](https://nyulangone.org/doctors/1033103759/thomas-m-wisniewski)
- [Steven L. Galetta, MD](https://nyulangone.org/doctors/1326072091/steven-l-galetta)
### Care & Services
[Neurology](https://nyulangone.org/care-services/neurology)
### Departments & Institutes
- [Department of Neurology](https://med.nyu.edu/departments-institutes/neurology/neurology)
### Education & Research
- [Research](https://med.nyu.edu/research)
### Need help finding a doctor?
[Search all doctors](https://nyulangone.org/doctors) or call 844-698-7243.
**T**he death of a loved one, financial or food insecurity, or a newly developed disability were some of the strongest predictors of whether a patient hospitalized for COVID-19 would experience symptoms of long COVID a year later, a new study finds.
Led by researchers from NYU Grossman School of Medicine, the study found that adult patients with such âmajor life stressorsââpresent in more than 50 percent of those followedâwere at least twice as likely to struggle with depression, brain fog, fatigue, sleep problems, and other long-term COVID-19 symptoms.
[Published online this week in the *Journal of the Neurological Sciences*](https://doi.org/10.1016/j.jns.2022.120487), the analysis also confirmed the contribution of traditional factors to greater long COVID risk as shown by past studiesâolder age, disability level to start with, and a more severe initial case of COVID-19.
âOur study is unique in that it explores the impact of life stressorsâalong with demographic trends and neurologic eventsâas predictors of long-term cognitive and functional disabilities that affected quality of life in a large population,â says lead study author [Jennifer A. Frontera, MD](https://nyulangone.org/doctors/1669420550/jennifer-a-frontera), professor in the [Department of Neurology](https://med.nyu.edu/departments-institutes/neurology) at NYU Langone Health. âTherapies that lessen the trauma of the most stress-inducing life events need to be a central part of treatment for long COVID, with more research needed to validate the best approaches.â
The research used standard telephone survey tools in the fieldâthe modified Rankin Scale (mRS), the Barthel Index, the Montreal Cognitive Assessment (t-MoCA), and the National Institutes of Health (NIH)/Patient-Reported Outcomes Measurement Information System (PROMIS) Neurological Quality Of Life (NeuroQoL) batteriesâto measure level of daily function, clear thinking (cognition), [anxiety](https://nyulangone.org/conditions/anxiety-disorders), [depression](https://nyulangone.org/conditions/depression), fatigue, and sleep quality. The team attempted to follow up with each of 790 patients 6 months and a year after COVID-19 hospitalization within NYU Langone Health between March 10, 2020, and May 20, 2020.
Of these surviving patients, 451 (57 percent) completed a 6-month and/or 12-month follow-up, and, of them, 17 percent died between discharge and 12-month follow-up and 51 percent reported significant life stressors at 12 months.
In analyses that compared factors against each other for their contribution to worse outcomes, life stressors including financial insecurity, food insecurity, death of a close contact, and new disability were the strongest independent predictors of prolonged COVID-19 symptoms. These same stressors also best predicted worse functional status, depression, fatigue, sleep scores, and reduced ability to participate in activities of daily living such as feeding, dressing, and bathing.
Gender was also a contributor, as past studies have found that women are more susceptible in general to, for instance, autoimmune diseases that could have an impact on outcomes. Additionally, undiagnosed mood disorders may have been unmasked by pandemic-related stressors.
## Neurologic Long COVID May Include More Than One Condition
A second study led by Dr. Frontera and colleagues, and [published online September 29, 2022, in *PLOS ONE*](https://doi.org/10.1371/journal.pone.0275274), found that patients diagnosed as having long COVID neurologic problems can be divided into three symptom groups.
Because there is no current biological definition long COVID, many studies lump disparate symptoms into what is currently a blanket diagnosis, and without an assessment of clinical relevance, says Dr. Frontera. The resulting vagueness has made it âdifficult to assess treatment strategies.â
For the *PLOS One* study, the research team collected data on symptoms, treatments received, and outcomes for 12 months after hospitalization with COVID-19, with treatment success measured again by standard metrics (modified Rankin Scale, Barthel Index, NIH NeuroQoL). The three newly identified disease groups were as follows:
- Cluster 1: few symptoms (most commonly [headache](https://nyulangone.org/conditions/headache)) who received few therapeutic interventions
- Cluster 2: many symptoms including anxiety and depression who received several treatments, including [antidepressants](https://nyulangone.org/conditions/depression/treatments/medication-for-depression) to [psychological therapy](https://nyulangone.org/conditions/depression/treatments/therapy-for-depression)
- Cluster 3: primarily pulmonary symptoms such as shortness of breath; many patients also complained of headache and cognitive symptoms, and mostly received physical therapy
The most severely affected patients (symptom Cluster 2) had higher rates of disability and worse measures of anxiety, depression, fatigue, and sleep disorders. All patients whose treatment included psychiatric therapies reported symptom improvement, compared to 97 percent who received primarily physical or occupational therapy, and 83 percent who received few interventions.
The Brookings Institution estimated in August 2022 that roughly 16 million working-age Americans (aged 18 to 65) have long COVID, out of which 2 to 4 million are out of work due to long COVID.
Along with Dr. Frontera, authors of the *Journal of the Neurological Sciences* study from the Department of Neurology at NYU Langone Health were [Sakinah B. Sabadia](https://nyulangone.org/doctors/1578919122/sakinah-b-sabadia), [Ariane Lewis](https://nyulangone.org/doctors/1700046075/ariane-lewis), [Aaron S. Lord](https://nyulangone.org/doctors/1477759058/aaron-s-lord), [Kara R. Melmed](https://nyulangone.org/doctors/1013354745/kara-r-melmed), [Sujata P. Thawani](https://nyulangone.org/doctors/1043549108/sujata-p-thawani), [Laura J. Balcer](https://nyulangone.org/doctors/1902838121/laura-j-balcer), [Thomas M. Wisniewski](https://nyulangone.org/doctors/1033103759/thomas-m-wisniewski), and [Steven L. Galetta](https://nyulangone.org/doctors/1326072091/steven-l-galetta). Also authors were Dixon Yang of the Department of Neurology at NewYork-Presbyterian, Columbia Medical Center; Adam de Havenon in the Department of Neurology at Yale University School of Medicine; and Shadi Yaghi in the Department of Neurology at Brown University School of Medicine.
### Media Inquiries
Greg Williams
Phone: 212-404-3500
[gregory.williams@nyulangone.org](mailto:gregory.williams@nyulangone.org)
***
## Related Articles
- 
[Research](https://nyulangone.org/news/research), [Innovation](https://nyulangone.org/news/innovation), [Press Releases](https://nyulangone.org/news/press-releases)
## [Long COVID Linked to Alzheimerâs Disease Mechanisms](https://nyulangone.org/news/long-covid-linked-alzheimers-disease-mechanisms)
### Patients with long COVID have higher levels of blood markers.
February 10, 2026
- 
[Research](https://nyulangone.org/news/research), [Press Releases](https://nyulangone.org/news/press-releases), [Artificial Intelligence](https://nyulangone.org/news/artificial-intelligence)
## [Researchers Find Brain Mechanism Behind âFlashes of Intuitionâ](https://nyulangone.org/news/researchers-find-brain-mechanism-behind-flashes-intuition)
### NYU Langone Health researchers have a better understanding of the type of memory known to go awry in those who have schizophrenia.
February 4, 2026
We can help you find a doctor. Call [646-929-7800](tel:646-929-7800) or
[browse our specialists](https://nyulangone.org/doctors).
## Explore NYU Langone
Patient Care
Expand menu
- [Conditions We Treat](https://nyulangone.org/conditions)
- [Locations](https://nyulangone.org/locations)
- [Emergency Care](https://nyulangone.org/care-services/emergency-care)
- [Virtual Urgent Care](https://nyulangone.org/care-services/virtual-urgent-care)
- [Insurance & Billing](https://nyulangone.org/insurance-billing-financial-assistance)
About Us
Expand menu
- [Our Story](https://nyulangone.org/our-story)
- [Jobs . Opens in a new tab](https://jobs.nyulangone.org/)
- [Vendor & Supplier Information](https://nyulangone.org/vendor-supplier-information)
- [Contact Us](https://nyulangone.org/contact-us)
How to Help
Expand menu
- [Give . Opens in a new tab](https://give.nyulangone.org/)
- [Volunteer](https://nyulangone.org/volunteer)
- [Blood Donation](https://nyulangone.org/blood-donation)
- [Organ & Tissue Donation](https://nyulangone.org/organ-tissue-donation)
Stay Connected
Expand menu
- [NYU Langone Health App](https://nyulangone.org/apps/nyu-langone-health-app)
- [Press Releases](https://nyulangone.org/news/press-releases)
- [Media Resources . Opens in a new tab](https://nyulangone.org/news/media-resources)
Education & Research
Expand menu
- [NYU Grossman School of Medicine . Opens in a new tab](https://med.nyu.edu/)
- [NYU Grossman Long Island School of Medicine . Opens in a new tab](https://medli.nyu.edu/)
- [NYU Health Sciences Library . Opens in a new tab](https://hsl.med.nyu.edu/)
- [New York University . Opens in a new tab](https://www.nyu.edu/)
Follow Us
- [Follow us on Facebook. Opens in a new window.](https://www.facebook.com/NYULangone)
- [đ Follow us on X. Opens in a new window.](https://twitter.com/nyulangone)
- [Follow us on Instagram. Opens in a new window.](https://www.instagram.com/nyulangone/)
- [Subscribe to our YouTube channel. Opens in a new window.](https://www.youtube.com/c/NYULangoneHealth)
- [Follow us on LinkedIn. Opens in a new window.](https://www.linkedin.com/company/nyulangonehealth)
[](https://nyulangone.org/)
- Š 2026 NYU Langone Hospitals
- [Price Transparency](https://med.nyu.edu/standard-charges/)
- [Policies & Disclaimers](https://nyulangone.org/policies-disclaimers)
- [Public Notices](https://nyulangone.org/public-notices)
- [Websites Privacy Policy](https://nyulangone.org/policies-disclaimers/websites-privacy-policy)
- [Accessibility](https://nyulangone.org/policies-disclaimers/accessibility)
- Accessibility Help Line: [855-698-9991](tel:855-698-9991)
Current site Current page
[Close](https://nyulangone.org/news/severely-stressful-events-worsen-symptoms-long-covid) |
| Readable Markdown | **T**he death of a loved one, financial or food insecurity, or a newly developed disability were some of the strongest predictors of whether a patient hospitalized for COVID-19 would experience symptoms of long COVID a year later, a new study finds.
Led by researchers from NYU Grossman School of Medicine, the study found that adult patients with such âmajor life stressorsââpresent in more than 50 percent of those followedâwere at least twice as likely to struggle with depression, brain fog, fatigue, sleep problems, and other long-term COVID-19 symptoms.
[Published online this week in the *Journal of the Neurological Sciences*](https://doi.org/10.1016/j.jns.2022.120487), the analysis also confirmed the contribution of traditional factors to greater long COVID risk as shown by past studiesâolder age, disability level to start with, and a more severe initial case of COVID-19.
âOur study is unique in that it explores the impact of life stressorsâalong with demographic trends and neurologic eventsâas predictors of long-term cognitive and functional disabilities that affected quality of life in a large population,â says lead study author [Jennifer A. Frontera, MD](https://nyulangone.org/doctors/1669420550/jennifer-a-frontera), professor in the [Department of Neurology](https://med.nyu.edu/departments-institutes/neurology) at NYU Langone Health. âTherapies that lessen the trauma of the most stress-inducing life events need to be a central part of treatment for long COVID, with more research needed to validate the best approaches.â
The research used standard telephone survey tools in the fieldâthe modified Rankin Scale (mRS), the Barthel Index, the Montreal Cognitive Assessment (t-MoCA), and the National Institutes of Health (NIH)/Patient-Reported Outcomes Measurement Information System (PROMIS) Neurological Quality Of Life (NeuroQoL) batteriesâto measure level of daily function, clear thinking (cognition), [anxiety](https://nyulangone.org/conditions/anxiety-disorders), [depression](https://nyulangone.org/conditions/depression), fatigue, and sleep quality. The team attempted to follow up with each of 790 patients 6 months and a year after COVID-19 hospitalization within NYU Langone Health between March 10, 2020, and May 20, 2020.
Of these surviving patients, 451 (57 percent) completed a 6-month and/or 12-month follow-up, and, of them, 17 percent died between discharge and 12-month follow-up and 51 percent reported significant life stressors at 12 months.
In analyses that compared factors against each other for their contribution to worse outcomes, life stressors including financial insecurity, food insecurity, death of a close contact, and new disability were the strongest independent predictors of prolonged COVID-19 symptoms. These same stressors also best predicted worse functional status, depression, fatigue, sleep scores, and reduced ability to participate in activities of daily living such as feeding, dressing, and bathing.
Gender was also a contributor, as past studies have found that women are more susceptible in general to, for instance, autoimmune diseases that could have an impact on outcomes. Additionally, undiagnosed mood disorders may have been unmasked by pandemic-related stressors.
## Neurologic Long COVID May Include More Than One Condition
A second study led by Dr. Frontera and colleagues, and [published online September 29, 2022, in *PLOS ONE*](https://doi.org/10.1371/journal.pone.0275274), found that patients diagnosed as having long COVID neurologic problems can be divided into three symptom groups.
Because there is no current biological definition long COVID, many studies lump disparate symptoms into what is currently a blanket diagnosis, and without an assessment of clinical relevance, says Dr. Frontera. The resulting vagueness has made it âdifficult to assess treatment strategies.â
For the *PLOS One* study, the research team collected data on symptoms, treatments received, and outcomes for 12 months after hospitalization with COVID-19, with treatment success measured again by standard metrics (modified Rankin Scale, Barthel Index, NIH NeuroQoL). The three newly identified disease groups were as follows:
- Cluster 1: few symptoms (most commonly [headache](https://nyulangone.org/conditions/headache)) who received few therapeutic interventions
- Cluster 2: many symptoms including anxiety and depression who received several treatments, including [antidepressants](https://nyulangone.org/conditions/depression/treatments/medication-for-depression) to [psychological therapy](https://nyulangone.org/conditions/depression/treatments/therapy-for-depression)
- Cluster 3: primarily pulmonary symptoms such as shortness of breath; many patients also complained of headache and cognitive symptoms, and mostly received physical therapy
The most severely affected patients (symptom Cluster 2) had higher rates of disability and worse measures of anxiety, depression, fatigue, and sleep disorders. All patients whose treatment included psychiatric therapies reported symptom improvement, compared to 97 percent who received primarily physical or occupational therapy, and 83 percent who received few interventions.
The Brookings Institution estimated in August 2022 that roughly 16 million working-age Americans (aged 18 to 65) have long COVID, out of which 2 to 4 million are out of work due to long COVID.
Along with Dr. Frontera, authors of the *Journal of the Neurological Sciences* study from the Department of Neurology at NYU Langone Health were [Sakinah B. Sabadia](https://nyulangone.org/doctors/1578919122/sakinah-b-sabadia), [Ariane Lewis](https://nyulangone.org/doctors/1700046075/ariane-lewis), [Aaron S. Lord](https://nyulangone.org/doctors/1477759058/aaron-s-lord), [Kara R. Melmed](https://nyulangone.org/doctors/1013354745/kara-r-melmed), [Sujata P. Thawani](https://nyulangone.org/doctors/1043549108/sujata-p-thawani), [Laura J. Balcer](https://nyulangone.org/doctors/1902838121/laura-j-balcer), [Thomas M. Wisniewski](https://nyulangone.org/doctors/1033103759/thomas-m-wisniewski), and [Steven L. Galetta](https://nyulangone.org/doctors/1326072091/steven-l-galetta). Also authors were Dixon Yang of the Department of Neurology at NewYork-Presbyterian, Columbia Medical Center; Adam de Havenon in the Department of Neurology at Yale University School of Medicine; and Shadi Yaghi in the Department of Neurology at Brown University School of Medicine.
### Media Inquiries
Greg Williams
Phone: 212-404-3500
[gregory.williams@nyulangone.org](mailto:gregory.williams@nyulangone.org) |
| Shard | 134 (laksa) |
| Root Hash | 13117336243312376934 |
| Unparsed URL | org,nyulangone!/news/severely-stressful-events-worsen-symptoms-long-covid s443 |